Search Results - "Kwon, Hyunjoo"

Refine Results
  1. 1

    Yes‐Associated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes the Development of Nonalcoholic Steatohepatitis by Song, Kyoungsub, Kwon, Hyunjoo, Han, Chang, Chen, Weina, Zhang, Jinqiang, Ma, Wenbo, Dash, Srikanta, Gandhi, Chandrashekhar R., Wu, Tong

    Published in Hepatology (Baltimore, Md.) (01-07-2020)
    “…Background and Aims Yes‐associated protein (YAP) plays an important role in hepatocarcinogenesis, although the potential role of YAP in non‐neoplastic liver…”
    Get full text
    Journal Article
  2. 2

    Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation by Kwon, Hyunjoo, Song, Kyoungsub, Han, Chang, Zhang, Jinqiang, Lu, Lu, Chen, Weina, Wu, Tong

    Published in The American journal of pathology (01-10-2017)
    “…Aberrant expression and regulation of miRNAs have been implicated in multiple stages of tumorigenic processes. The current study was designed to explore the…”
    Get full text
    Journal Article
  3. 3

    Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway by Kwon, Hyunjoo, Song, Kyoungsub, Han, Chang, Zhang, Jinqiang, Lu, Lu, Chen, Weina, Wu, Tong

    Published in The American journal of pathology (01-10-2017)
    “…Aberrant expression and regulation of miRNAs have been implicated in multiple stages of tumorigenic processes. The current study was designed to explore the…”
    Get full text
    Journal Article
  4. 4

    The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway by Ma, Wenbo, Han, Chang, Zhang, Jinqiang, Song, Kyoungsub, Chen, Weina, Kwon, Hyunjoo, Wu, Tong

    Published in Hepatology (Baltimore, Md.) (01-10-2020)
    “…Background and Aims Cholangiocarcinoma (CCA) is a highly malignant epithelial tumor of the biliary tree with poor prognosis. In the current study, we present…”
    Get full text
    Journal Article
  5. 5

    Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease by Kwon, Hyunjoo, Song, Kyoungsub, Han, Chang, Chen, Weina, Wang, Ying, Dash, Srikanta, Lim, Kyu, Wu, Tong

    Published in Hepatology (Baltimore, Md.) (01-04-2016)
    “…Hedgehog (Hh) signaling plays a critical role in liver development, regeneration, injury repair, and carcinogenesis. Activation of Hh signaling has been…”
    Get full text
    Journal Article
  6. 6

    A Transforming Growth Factor‐β and H19 Signaling Axis in Tumor‐Initiating Hepatocytes That Regulates Hepatic Carcinogenesis by Zhang, Jinqiang, Han, Chang, Ungerleider, Nathan, Chen, Weina, Song, Kyoungsub, Wang, Ying, Kwon, Hyunjoo, Ma, Wenbo, Wu, Tong

    Published in Hepatology (Baltimore, Md.) (01-04-2019)
    “…Functions of transforming growth factor‐β (TGF‐β) in the liver vary depending on specific cell types and their temporal response to TGF‐β during different…”
    Get full text
    Journal Article
  7. 7

    EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes by Zhang, Jinqiang, Chen, Weina, Ma, Wenbo, Han, Chang, Song, Kyoungsub, Kwon, Hyunjoo, Wu, Tong

    Published in The American journal of pathology (01-12-2022)
    “…Cholangiocarcinoma (CCA) is a highly malignant cancer of the biliary tree. Although studies have implicated enhancer of Zeste homolog 2 (EZH2) in CCA growth,…”
    Get full text
    Journal Article
  8. 8

    Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122 by Song, Kyoungsub, Kwon, Hyunjoo, Han, Chang, Zhang, Jinqiang, Dash, Srikanta, Lim, Kyu, Wu, Tong

    Published in Oncotarget (01-12-2015)
    “…Although altered metabolic pathway is an important diagnostic maker and therapeutic target in cancer, it is poorly understood in cancer stem cells (CSCs). Here…”
    Get full text
    Journal Article
  9. 9

    HM15912, a Novel Long-Acting Glucagon-Like Peptide-2 Analog, Improves Intestinal Growth and Absorption Capacity in a Male Rat Model of Short Bowel Syndrome by Choi, Jaehyuk, Lee, Jinbong, Park, Eunjin, Kwon, Hyunjoo, Kim, Daejin, Bae, Sungmin, Choi, In Young, Kim, Ha Hyung

    “…Extensive bowel resection caused by various diseases that affect the intestines, such as Crohn's disease, volvulus, and cancer, leads to short bowel syndrome…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    655-P: Multitarget Engagement Effect of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Animal Model of NASH by KIM, JUNG KUK, LEE, JONG SUK, KWON, HYUNJOO, PARK, EUNJIN, LEE, JONGSOO, BAE, SUNGMIN, LEE, SANG HYUN, CHOI, IN YOUNG

    Published in Diabetes (New York, N.Y.) (01-06-2021)
    “…NASH is a complex disease progressed by multiple mechanism. To date, no approved drug is available due to unsatisfied efficacy. Of note, recent studies…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    1830-P: Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in CDHFD-Induced NASH and Fibrosis Mice by CHOI, JAEHYUK, KIM, JUNG KUK, LEE, SEON MYEONG, KWON, HYUNJOO, LEE, JONGSOO, BAE, SUNGMIN, KIM, DAEJIN, CHOI, IN YOUNG

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Nonalcoholic steatohepatitis (NASH) is a progressive liver disease characterized by steatosis and inflammation, which results in fibrosis. In particular,…”
    Get full text
    Journal Article
  20. 20

    YAP in Kupffer cells enhances the production of pro-inflammatory cytokines and promotes the development of non-alcoholic steatohepatitis by Song, Kyoungsub, Kwon, Hyunjoo, Han, Chang, Chen, Weina, Zhang, Janqiang, Ma, Wenbo, Dash, Srikanta, Gandhi, Chandrashekhar R., Wu, Tong

    Published in Hepatology (Baltimore, Md.) (11-04-2020)
    “…Yes-associated protein (YAP) plays an important role in hepatocarcinogenesis, although the potential role of YAP in non-neoplastic liver diseases remains…”
    Get full text
    Journal Article